Medifast (MED) Shares Outstanding (2010 - 2026)

Medifast (MED) has 17 years of Shares Outstanding data on file, last reported at $11.1 million in Q1 2026.

• For the quarter ending Q1 2026, Shares Outstanding rose 1.16% year-over-year to $11.1 million; the trailing twelve-month figure through Mar 2026 stood at $11.1 million (up 1.16% YoY), and the FY2025 full-year result was $11.0 million, changed 0.48% from the prior year.
• Shares Outstanding for Q1 2026 stood at $11.1 million, up from $11.0 million in the prior quarter.
• Across five years, Shares Outstanding topped out at $11.6 million in Q1 2022 and bottomed at $10.9 million in Q1 2023.
• The 5-year median for Shares Outstanding is $10.9 million (2024), against an average of $11.0 million.
• The widest annual swing landed in 2022, when Shares Outstanding retreated 6.13%; it then increased 1.16% in 2026.
• A 5-year view of Shares Outstanding shows it stood at $10.9 million in 2022, then declined by 0.29% to $10.9 million in 2023, then increased by 0.39% to $10.9 million in 2024, then increased by 0.48% to $11.0 million in 2025, then grew by 1.16% to $11.1 million in 2026.
• The last three Shares Outstanding figures came in at $11.1 million (Q1 2026), $11.0 million (Q4 2025), and $11.0 million (Q3 2025), per Business Quant data.

Peer Comparison